198 related articles for article (PubMed ID: 26251144)
1. [Development of Tax-redirected T-cell immunotherapy using TCR gene transduction in patients with ATL].
Tanaka Y; Kanda Y
Rinsho Ketsueki; 2015 Jul; 56(7):815-24. PubMed ID: 26251144
[TBL] [Abstract][Full Text] [Related]
2. A Unique T-Cell Receptor Amino Acid Sequence Selected by Human T-Cell Lymphotropic Virus Type 1 Tax
Ishihara Y; Tanaka Y; Kobayashi S; Kawamura K; Nakasone H; Gomyo A; Hayakawa J; Tamaki M; Akahoshi Y; Harada N; Kusuda M; Kameda K; Ugai T; Wada H; Sakamoto K; Sato M; Terasako-Saito K; Kikuchi M; Kimura SI; Tanihara A; Kako S; Uchimaru K; Kanda Y
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724766
[TBL] [Abstract][Full Text] [Related]
3. Universal cytotoxic activity of a HTLV-1 Tax-specific T cell clone from an HLA-A*24:02⁺ patient with adult T-cell leukemia against a variety of HTLV-I-infected T-cells.
Tanaka Y; Yamazaki R; Terasako-Saito K; Nakasone H; Akahoshi Y; Nakano H; Ugai T; Wada H; Yamasaki R; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Sato M; Kimura S; Kikuchi M; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
Immunol Lett; 2014; 158(1-2):120-5. PubMed ID: 24389072
[TBL] [Abstract][Full Text] [Related]
4. Single-cell analysis of T-cell receptor repertoire of HTLV-1 Tax-specific cytotoxic T cells in allogeneic transplant recipients with adult T-cell leukemia/lymphoma.
Tanaka Y; Nakasone H; Yamazaki R; Sato K; Sato M; Terasako K; Kimura S; Okuda S; Kako S; Oshima K; Tanihara A; Nishida J; Yoshikawa T; Nakatsura T; Sugiyama H; Kanda Y
Cancer Res; 2010 Aug; 70(15):6181-92. PubMed ID: 20647322
[TBL] [Abstract][Full Text] [Related]
5. Long-term persistence of limited HTLV-I Tax-specific cytotoxic T cell clones in a patient with adult T cell leukemia/lymphoma after allogeneic stem cell transplantation.
Tanaka Y; Nakasone H; Yamazaki R; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Sato M; Terasako K; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
J Clin Immunol; 2012 Dec; 32(6):1340-52. PubMed ID: 22763862
[TBL] [Abstract][Full Text] [Related]
6. Potential contribution of a novel Tax epitope-specific CD4+ T cells to graft-versus-Tax effect in adult T cell leukemia patients after allogeneic hematopoietic stem cell transplantation.
Tamai Y; Hasegawa A; Takamori A; Sasada A; Tanosaki R; Choi I; Utsunomiya A; Maeda Y; Yamano Y; Eto T; Koh KR; Nakamae H; Suehiro Y; Kato K; Takemoto S; Okamura J; Uike N; Kannagi M
J Immunol; 2013 Apr; 190(8):4382-92. PubMed ID: 23475215
[TBL] [Abstract][Full Text] [Related]
7. Development of a Unique T Cell Receptor Gene-Transferred Tax-Redirected T Cell Immunotherapy for Adult T Cell Leukemia.
Kawamura K; Tanaka Y; Nakasone H; Ishihara Y; Kako S; Kobayashi S; Tanaka Y; Ohmori T; Uchimaru K; Okamoto S; Mineno J; Shiku H; Nishimura S; Kanda Y
Biol Blood Marrow Transplant; 2020 Aug; 26(8):1377-1385. PubMed ID: 32311478
[TBL] [Abstract][Full Text] [Related]
8. Graft-versus-Tax response in adult T-cell leukemia patients after hematopoietic stem cell transplantation.
Harashima N; Kurihara K; Utsunomiya A; Tanosaki R; Hanabuchi S; Masuda M; Ohashi T; Fukui F; Hasegawa A; Masuda T; Takaue Y; Okamura J; Kannagi M
Cancer Res; 2004 Jan; 64(1):391-9. PubMed ID: 14729650
[TBL] [Abstract][Full Text] [Related]
9. Gene expression and TCR amino acid sequences selected by HLA-A02:01-restricted CTLs specific to HTLV-1 in ATL patients.
Kusuda M; Nakasone H; Yoshimura K; Okada Y; Tamaki M; Matsuoka A; Ishikawa T; Meno T; Nakamura Y; Kawamura M; Takeshita J; Kawamura S; Yoshino N; Misaki Y; Gomyo A; Tanihara A; Kimura SI; Kako S; Kanda Y
Br J Haematol; 2023 Aug; 202(3):578-588. PubMed ID: 37317804
[TBL] [Abstract][Full Text] [Related]
10. Impact of host immunity on HTLV-1 pathogenesis: potential of Tax-targeted immunotherapy against ATL.
Kannagi M; Hasegawa A; Nagano Y; Kimpara S; Suehiro Y
Retrovirology; 2019 Aug; 16(1):23. PubMed ID: 31438973
[TBL] [Abstract][Full Text] [Related]
11. Advantage of higher-avidity CTL specific for Tax against human T-lymphotropic virus-1 infected cells and tumors.
Kitazono T; Okazaki T; Araya N; Yamano Y; Yamada Y; Nakamura T; Tanaka Y; Inoue M; Ozaki S
Cell Immunol; 2011; 272(1):11-7. PubMed ID: 22030472
[TBL] [Abstract][Full Text] [Related]
12. Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy.
Kannagi M; Hasegawa A; Nagano Y; Iino T; Okamura J; Suehiro Y
Cancer Sci; 2019 Mar; 110(3):849-857. PubMed ID: 30666755
[TBL] [Abstract][Full Text] [Related]
13. Potential role of HTLV-1 Tax-specific cytotoxic t lymphocytes expressing a unique t-cell receptor to promote inflammation of the central nervous system in myelopathy associated with HTLV-1.
Tanaka Y; Sato T; Yagishita N; Yamauchi J; Araya N; Aratani S; Takahashi K; Kunitomo Y; Nagasaka M; Kanda Y; Uchimaru K; Morio T; Yamano Y
Front Immunol; 2022; 13():993025. PubMed ID: 36081501
[TBL] [Abstract][Full Text] [Related]
14. Short-term cultured autologous peripheral blood mononuclear cells as a potential immunogen to activate Tax-specific CTL response in adult T-cell leukemia patients.
Ishizawa M; Ganbaatar U; Hasegawa A; Takatsuka N; Kondo N; Yoneda T; Katagiri K; Masuda T; Utsunomiya A; Kannagi M
Cancer Sci; 2021 Mar; 112(3):1161-1172. PubMed ID: 33410215
[TBL] [Abstract][Full Text] [Related]
15. Existence of escape mutant in HTLV-I tax during the development of adult T-cell leukemia.
Furukawa Y; Kubota R; Tara M; Izumo S; Osame M
Blood; 2001 Feb; 97(4):987-93. PubMed ID: 11159527
[TBL] [Abstract][Full Text] [Related]
16. Tumor immunity against adult T-cell leukemia.
Kannagi M; Harashima N; Kurihara K; Ohashi T; Utsunomiya A; Tanosaki R; Masuda M; Tomonaga M; Okamura J
Cancer Sci; 2005 May; 96(5):249-55. PubMed ID: 15904464
[TBL] [Abstract][Full Text] [Related]
17. Autologous Tax-specific CTL therapy in a primary adult T cell leukemia/lymphoma cell-bearing NOD/Shi-scid, IL-2Rγnull mouse model.
Masaki A; Ishida T; Suzuki S; Ito A; Mori F; Sato F; Narita T; Yamada T; Ri M; Kusumoto S; Komatsu H; Tanaka Y; Niimi A; Inagaki H; Iida S; Ueda R
J Immunol; 2013 Jul; 191(1):135-44. PubMed ID: 23733874
[TBL] [Abstract][Full Text] [Related]
18. The clinical impact of human T-lymphotrophic virus type 1 (HTLV-1) infection on the development of adult T-cell leukemia-lymphoma (ATL) or HTLV-1-associated myelopathy (HAM) / atypical HAM after allogeneic hematopoietic stem cell transplantation (allo-HSCT) and renal transplantation.
Kawano N; Yoshida S; Kawano S; Kuriyama T; Tahara Y; Toyofuku A; Manabe T; Doi A; Terasaka S; Yamashita K; Ueda Y; Ochiai H; Marutsuka K; Yamano Y; Shimoda K; Kikuchi I
J Clin Exp Hematop; 2018 Sep; 58(3):107-121. PubMed ID: 30089749
[TBL] [Abstract][Full Text] [Related]
19. A retrospective analysis of treatment outcomes in adult T cell leukemia/lymphoma patients with aggressive disease treated with or without allogeneic stem cell transplantation: A single-center experience.
Kawada H; Yoshimitsu M; Nakamura D; Arai A; Hayashida M; Kamada Y; Maekawa K; Fujino S; Arima M; Arima N; Tabuchi T; Inoue H; Hamda H; Suzuki S; Matsushita K; Arima N
Biol Blood Marrow Transplant; 2015 Apr; 21(4):696-700. PubMed ID: 25542158
[TBL] [Abstract][Full Text] [Related]
20. Development of a novel redirected T-cell-based adoptive immunotherapy targeting human telomerase reverse transcriptase for adult T-cell leukemia.
Miyazaki Y; Fujiwara H; Asai H; Ochi F; Ochi T; Azuma T; Ishida T; Okamoto S; Mineno J; Kuzushima K; Shiku H; Yasukawa M
Blood; 2013 Jun; 121(24):4894-901. PubMed ID: 23641014
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]